Revenue for Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's current revenue (TTM) is $20.61B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$20.61B
YoY change
+19.9%
5Y CAGR
+15.2%
Peak year (2025)
$20.07B
Cumulative revenue
$235.16B
Revenue history chart for Boston Scientific (BSX) from 1991 to 2025
Revenue history table for Boston Scientific (BSX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $20.07B | +19.9% | ||
| 2024 | $16.75B | +17.6% | ||
| 2023 | $14.24B | +12.3% | ||
| 2022 | $12.68B | +6.7% | ||
| 2021 | $11.89B | +19.9% | ||
| 2020 | $9.91B | -7.7% | ||
| 2019 | $10.73B | +9.3% | ||
| 2018 | $9.82B | +8.6% | ||
| 2017 | $9.05B | +7.9% | ||
| 2016 | $8.39B | +12.2% | ||
| 2015 | $7.48B | +1.3% | ||
| 2014 | $7.38B | +3.3% | ||
| 2013 | $7.14B | -1.5% | ||
| 2012 | $7.25B | -4.9% | ||
| 2011 | $7.62B | -2.4% | ||
| 2010 | $7.81B | -4.7% | ||
| 2009 | $8.19B | +1.7% | ||
| 2008 | $8.05B | -3.7% | ||
| 2007 | $8.36B | +6.9% | ||
| 2006 | $7.82B | +24.5% | ||
| 2005 | $6.28B | +11.7% | ||
| 2004 | $5.62B | +61.8% | ||
| 2003 | $3.48B | +19.1% | ||
| 2002 | $2.92B | +9.2% | ||
| 2001 | $2.67B | +0.3% | ||
| 2000 | $2.66B | -6.3% | ||
| 1999 | $2.84B | +27.2% | ||
| 1998 | $2.23B | +19.3% | ||
| 1997 | $1.87B | +28.1% | ||
| 1996 | $1.46B | +32.1% | ||
| 1995 | $1.11B | +146.6% | ||
| 1994 | $448.90M | +18.1% | ||
| 1993 | $380.10M | +20.6% | ||
| 1992 | $315.20M | +37.0% | ||
| 1991 | $230.00M | — |
Revenue values are taken from Boston Scientific's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Boston Scientific (BSX) revenue is $20.07B – grew 19.9% year-over-year.
Boston Scientific revenue has grown for 5 consecutive years, with a +15.2% compound annual growth rate over 2020–2025 (5 years).
The highest annual revenue of $20.07B was reported in 2025. The lowest in the available history was $230.00M in 1991.
Among 8 Healthcare peers, Boston Scientific (BSX) ranks 9th; the peer median for revenue is $65.09B.
Boston Scientific Revenue by Year
Boston Scientific Revenue 2025: $20.07B
Boston Scientific revenue in 2025 was $20.07B, grew 19.9% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Revenue 2024: $16.75B
Boston Scientific revenue in 2024 was $16.75B, grew 17.6% from 2023.
Boston Scientific Revenue 2023: $14.24B
Boston Scientific revenue in 2023 was $14.24B, grew 12.3% from 2022.
Boston Scientific Revenue 2022: $12.68B
Boston Scientific revenue in 2022 was $12.68B, grew 6.7% from 2021.
Boston Scientific Revenue 2021: $11.89B
Boston Scientific revenue in 2021 was $11.89B.
See more financial history for Boston Scientific (BSX).
Sector peers — Revenue
Companies in the same sector as Boston Scientific, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Boston Scientific's revenue?
- Latest reported revenue for Boston Scientific (BSX) is $20.61B (period ending March 31, 2026).
How has Boston Scientific revenue changed year-over-year?
- Boston Scientific (BSX) revenue changed +19.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Boston Scientific revenue?
- Boston Scientific (BSX) revenue compound annual growth rate is +15.2% over the most recent 5 years available.
When did Boston Scientific revenue hit its highest annual value?
- Boston Scientific revenue reached its highest annual value of $20.07B in 2025.
What was Boston Scientific revenue in 2024?
- Boston Scientific (BSX) revenue in 2024 was $16.75B.
What was Boston Scientific revenue in 2025?
- Boston Scientific (BSX) revenue in 2025 was $20.07B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BSX Overview
Company profile, financial tools, and key metrics
BSX Revenue Counter
Earns $653.70 every second. See per minute, hour, and day.
BSX Earnings Counter
Earns $112.66 per second net profit. See per minute, hour, and day.
BSX Economic Scale
Exceeds Niger's GDP. Compare with world economies.
BSX What If Invested
What if you had invested $1,000? See historical returns from any date.
BSX How It Makes Money
Discover visual breakdown of $20.61B in revenue — where it comes from and where it goes.
BSX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BSX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BSX Daily Price Character
Balanced · 48.8% historical win rate (green days). Streaks & record days.
BSX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BSX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.